Regeneron Pharmaceuticals, Inc.
METHODS OF TREATING ALLERGY USING ANTI-BET V 1 ANTIBODIES

Last updated:

Abstract:

The present disclosure provides methods for treating, preventing, or ameliorating one or more symptoms of birch allergy or allergic disease in a subject by administering to the subject an antibody or antigen-binding fragment thereof that binds Bet v 1, or a cocktail of antibodies or antigen-binding fragments thereof that bind Bet v 1.

Status:
Application
Type:

Utility

Filling date:

30 Jun 2021

Issue date:

6 Jan 2022